Omnipod 5
Sponsors
Universitaire Ziekenhuizen KU Leuven, Insulet Corporation, University Hospital, Montpellier, Imperial College London, Helsinki University Central Hospital
Conditions
Chronic Kidney Disease 5DDiabetesDiabetes MellitusDiabetes Mellitus, Type 1Type 1 DiabetesType 2 Diabetes
Unknown Phase
The Impact of Hybrid Closed-loop Insulin Delivery in Type 1 Diabetes on Glycemic Control and PROMs
Active, not recruitingNCT04414280
Start: 2020-03-12End: 2028-04-01Target: 1600Updated: 2026-05-27
Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes
RecruitingNCT06144554
Start: 2023-09-25End: 2028-09-01Target: 2200Updated: 2026-07-01
Efficacy of Automated Insulin Therapy Early Initiated After Diagnosis on Blood Glucose Control in Children and Adolescents With Type 1 Diabetes
RecruitingNCT06283797
Start: 2024-05-29End: 2027-06-29Target: 112Updated: 2025-04-06
French Prospective Multicentric Study in Real World
Active, not recruitingNCT07039942
Start: 2025-07-23End: 2027-10-01Target: 304Updated: 2026-07-02
Omnipod-5 A French Prospective Multicentric Study in Real World (Optimal-B)
RecruitingNCT07317102
Start: 2026-03-16End: 2027-11-01Target: 152Updated: 2026-07-02
The Impact of Early Automated Insulin Delivery (AID) Therapy on Diabetes Control and Comorbidities, and Cost-effectiveness of AID Treatment
Not yet recruitingNCT07423637
Start: 2026-04-01End: 2028-12-31Target: 100Updated: 2026-03-17
A Multi-centre Trial to Assess the Efficacy and Safety of the Omnipod 5 System in People With Type 2 Diabetes Undergoing Haemodialysis
Not yet recruitingNCT07422532
Start: 2026-04-01End: 2027-04-01Target: 84Updated: 2026-02-20